[HTML][HTML] Viral hepatitis: Past, present, and future
MA Odenwald, S Paul - World journal of gastroenterology, 2022 - ncbi.nlm.nih.gov
Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …
[HTML][HTML] Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis
LM Kucirka, H Sarathy, P Govindan, JH Wolf… - American Journal of …, 2011 - Elsevier
The OPTN classifies high infectious risk donors (HRDs) based on criteria originally intended
to identify people at risk for HIV infection. These donors are sometimes referred to as 'CDC …
to identify people at risk for HIV infection. These donors are sometimes referred to as 'CDC …
Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection
Clinical infectious diseases, 2018 - academic.oup.com
Recognizing the importance of timely guidance regarding the rapidly evolving field of
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
[HTML][HTML] Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection
AIHCVG Panel - Clinical infectious diseases: an official publication …, 2018 - ncbi.nlm.nih.gov
Recognizing the importance of timely guidance regarding the rapidly evolving field of
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus–infected donors to noninfected recipients: an open-label nonrandomized trial
CM Durand, MG Bowring, DM Brown… - Annals of internal …, 2018 - acpjournals.org
Background: Given the high mortality rate for patients with end-stage kidney disease
receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments …
receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments …
The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study
Background: The epidemic of drug overdose deaths in the United States has led to an
increase in organ donors. Objective: To characterize donors who died of overdose and to …
increase in organ donors. Objective: To characterize donors who died of overdose and to …
Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
MZ Molnar, S Nair, O Cseprekal… - American Journal of …, 2019 - Wiley Online Library
Our aim was to evaluate the safety of transplanting kidneys from HCV‐infected donors in
HCV‐uninfected recipients. Data collected from 53 recipients in a single center …
HCV‐uninfected recipients. Data collected from 53 recipients in a single center …
Transplanting hepatitis C–positive kidneys
PP Reese, PL Abt, EA Blumberg… - New England Journal …, 2015 - Mass Medical Soc
Transplanting Hepatitis C–Positive Kidneys | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Hepatitis C virus NAT‐positive solid organ allografts transplanted into hepatitis C virus–negative recipients: a real‐world experience
N Kapila, KVN Menon, K Al‐Khalloufi, JM Vanatta… - …, 2020 - Wiley Online Library
Background and Aims Hepatitis C virus (HCV)‐viremic organs are underutilized, and there is
limited real‐world experience on the transplantation of HCV‐viremic solid organs into …
limited real‐world experience on the transplantation of HCV‐viremic solid organs into …
[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …